FDA Approves First Nasal Spray for Treatment of Anaphylaxis
August 09, 2024
Today, the U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are life-threatening (anaphylaxis), in adult and pediatric patients who weigh at least 30 kilograms (about 66 pounds).
/profile/de688360-0d0f-4773-8ff7-1f1170ada83a.jpeg){kind=small}
/embed_images/86f5901b-74b9-4523-a36f-be6c05af5321.jpeg)